Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
SBI Healthcare Opp Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.13.97712800000513.0440
Domestic EquitiesDivi's Laboratories Ltd.6.6332400000243.4800
Domestic EquitiesMax Healthcare Institute Ltd.6.28292100000230.6220
Domestic EquitiesCipla Ltd.5.06761200000186.0120
Domestic EquitiesLupin Ltd.4.7957840000176.0304
Domestic EquitiesPolymedicure Ltd.3.7867540000138.9960
Domestic EquitiesMankind Pharma Ltd.3.7611560000138.0568
Domestic EquitiesKrishna Institute of Medical Sciences Ltd.3.64052034372133.6277
Domestic EquitiesJupiter Life Line Hospitals Ltd.3.1986800000117.4080
Domestic EquitiesFortis Healthcare Ltd.3.13771680000115.1724
Domestic EquitiesAmi Organics Ltd.3.08011000000113.0600
Domestic EquitiesAether Industries Ltd.3.07171400000112.7490
Domestic EquitiesAbbott India Ltd.2.940836000107.9460
Domestic EquitiesAster DM Healthcare Ltd.2.88892100000106.0395
Domestic EquitiesAlkem Laboratories Ltd.2.7875200000102.3200
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.715130000099.6600
Domestic EquitiesAurobindo Pharma Ltd.2.678880000098.3280
Domestic EquitiesLaurus Labs Ltd.2.4676150000090.5775
Domestic EquitiesRainbow Children's Medicare Ltd.2.409164000088.4288
Domestic EquitiesGland Pharma Ltd.2.059654000075.6000
Domestic EquitiesBiocon Ltd.1.7534200000064.3600
Domestic EquitiesSuven Pharmaceuticals Ltd.1.672854000061.4034
Domestic EquitiesConcord Biotech Ltd.1.654940000060.7440
Domestic EquitiesVijaya Diagnostic Centre Ltd.1.635460000060.0300
Domestic EquitiesPfizer Ltd.1.169510000042.9280
Domestic EquitiesAkums Drugs & Pharmaceuticals Ltd.1.150680874642.2327
Domestic EquitiesSanofi Consumer Healthcare India Ltd.1.00947500037.0500
Domestic EquitiesGufic Biosciences Ltd.1.0017100000036.7700
Total 92.4280 3392.6762
Cash & Cash Equivalents and Net AssetsTREPS1.7321 63.5780
Cash & Cash Equivalents and Net AssetsNet Receivable / Payable0.7912 29.0408
Total 2.5232 92.6188
Treasury Bills182 DAY T-BILL 05.06.250.08133000002.9832
Total 0.0813 2.9832
Overseas EquitiesLonza Group4.9675300000182.3377
Total 4.9675 182.3377
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.